A/Prof Joe Cardaci
/content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Joe_Cardaci.jpeg

A/Prof. Joe Cardaci

A/Prof. Joe Cardaci
Joe
Cardaci
Nuclear Medicine Physician, MBBS, FRACP, AANNMS

It is a privilege to be able to work with patients with advanced malignancies, who may be dealing with uncertain outcomes. I aim to offer personalised, evidence-based care to my patients.

Languages spoken

English, Italian

Overview

Centres

Murdoch (Oncology)
Murdoch (Oncology)
St John of God Murdoch Hospital, 100 Murdoch Drive, Murdoch, WA, 6150, Australia
-32.067130818740424, 115.84572533810733
/au/our-centres/murdoch-oncology
WA

Clinical interests in prostate cancer and neuroendocrine tumours (NETs).

Dr Cardaci is a Nuclear Medicine Physician with a long-standing interest in theranostics. He was involved in the early development of SIRT therapy for liver cancer. He has been involved in multiple international research trials advancing the field of radionuclide therapy in advanced malignancies. Dr Cardaci's clinical interests are advanced prostate cancer, neuroendocrine tumours (NETs), and liver cancer.

Dr Cardaci also practices as a General Medicine Physician, overseeing a busy medical department at Hollywood Private Hospital, Perth. He is actively engaged in medical student and Basic Physician training, and is Adjunct Associate Professor at University of Notre Dame

Research interests

  • Novel treatments for hard-to-treat cancers and radionuclide therapies.

Professional memberships

  • FRACP
  • AANMS

Publications

  • Kesavan M, Turner JH, Meyrick D, Yeo S, Cardaci G, Lenzo NP.  Salvage radiopeptide therapy of advanced castrate-resistant prostate cancer with Lutetium-177-labelled Prostate-Specific Membrane Antigen: Efficacy and safety in routine practice. Cancer Biother Radiopharm. 2018 Sep;33(7):274-281.
  • Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B.  Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004 Nov 1;88(2):78-85.